Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018
[Therapy of asthenoneurotic syndrome in patients with focal muscular dystonia].
СтатьяНазвание и аннотация: Оригинал на русском
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suvorova V A, Antipenko E A
Аннотация
AIM: To analyze the prevalence and structure of asthenoneurotic disorders in patients with focal muscular dystonia and determine an effect of the anxiolytic аdaptol (tetramethyltetraazabicyclooctandion) on asthenic syndrome in muscular dystonia.
MATERIAL AND METHODS: Forty patients with focal muscular dystonia were examined. The severity of asthenic syndrome (MFI-20), anxiety (the Hospital scale of anxiety and depression) and depression (the Hamilton Depression Rating Scale) were evaluated.
RESULTS AND CONCLUSION: Asthenic syndrome and anxiety disorder are independent non-motor manifestations of focal muscular dystonia. Adaptol has a positive effect, significantly reducing anxiety and asthenia in patients with focal muscular dystonia.
MATERIAL AND METHODS: Forty patients with focal muscular dystonia were examined. The severity of asthenic syndrome (MFI-20), anxiety (the Hospital scale of anxiety and depression) and depression (the Hamilton Depression Rating Scale) were evaluated.
RESULTS AND CONCLUSION: Asthenic syndrome and anxiety disorder are independent non-motor manifestations of focal muscular dystonia. Adaptol has a positive effect, significantly reducing anxiety and asthenia in patients with focal muscular dystonia.